Growth Equity

Australian GRC leader Protecht buys US-based VISO TRUST, integrating advanced AI to automate security and dominate the rapidly expanding risk management market.

A Japanese startup’s ultra-fast genome accelerator joins a national AI program, aiming to slash sequencing time and democratize advanced healthcare.

Singapore's aquatic education leader prices a complex public offering to fuel a pivot into new sports, facing investor scrutiny and a volatile stock history.

With $4M GTD, Americas Cardroom's High Five series is back, now featuring elite 'Highest Five' events to attract pros alongside its inclusive schedule.

American Uranium secures over 1,000 acres at its Lo Herma project, bolstering domestic uranium resources amid a global nuclear energy resurgence.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

With a successful $191M IPO, Alamar Biosciences is set to revolutionize diagnostics with its ultra-sensitive proteomics platforms.

BTG Pactual TIG is funneling billions into Latin American timber, blending high finance with ambitious climate and biodiversity goals. What's behind this green gold rush?

Deep-tech firm AHOY surpasses $100M ARR with its "Real-World AI," now seeking major funding to expand its sovereign AI for critical infrastructure.

Tech-driven supply platform Odeko acquires a 37-year-old Boston distributor and enters Nashville, signaling a major shift for independent cafes.

With founder Frédéric Mascha as Executive Chairman and new CEO Renaud Sermondade, Juvisé Pharmaceuticals is poised for major M&A-fueled global expansion.

A luxury brand and an NGO award women in bio-tech and MedTech, tackling the stark funding gap and championing a new generation of impact-driven founders.

Hospitality platform Listo is rapidly expanding into the nation's top venues, using its software to cut costs and perfect the fan experience behind the scenes.

Win a VIP trip to meet P!NK while supporting vital cancer research. A new fundraising model emerges as public funding for life-saving science dwindles.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

Cleaning solutions giant Zep appoints turnaround specialist Tim Feast as CEO, signaling a new era of growth under private equity owner Truelink Capital.

Software pioneer Horizon Quantum acquires a powerful 256-qubit IonQ computer, a key step in creating a universal platform for quantum developers.

Transom Capital Group appoints Luke Dauch, a decade-long J.P. Morgan banker, to bolster its deal origination in a competitive middle-market landscape.

With a new MD and key promotions, the firm signals a strategic push to deepen its human capital and investor relations for its next growth phase.

With $10M, Livid offers Vimeo users an escape from Bending Spoons' playbook of price hikes, backed by a free one-click video migration tool.